A study on Institutional oversight and the effectiveness of clinical trial strategic alliances

Authors

  • Nisha R Rijhwani Research Scholar, Saurashtra University, Rajkot, Gujarat Author

DOI:

https://doi.org/10.31305/rrijm2022.v02.n04.004

Keywords:

regulation, formal institution, interorganizational relationships, relational capability

Abstract

This research seeks to evaluate the efficacy and efficiency of clinical-trial strategic partnerships by examining their connections to the country's regulatory agencies. The country's formal institutions, i.e. its defined norms, are what ultimately govern the behaviour of social actors. A strategic alliance is a voluntary, long-term cooperation arrangement between two or more independent businesses with complementary strengths and objectives in order to gain a market advantage. Organizational effectiveness and efficiency are reflected in the performance of clinical-trial strategic alliances, which are structured according to the contractual relationship and the relational capabilities of the parties to overcome challenges in the partnership's activities and ensure intercompany cooperation. This research built on a previous critical literature assessment by proposing new hypotheses on the connections between national regulatory bodies and international partnerships for testing experimental pharmaceuticals in humans.

References

Almeida, J. D., & Costa, P. D. (2017). Development of relational capability in technology-based companies in the information and communication technology sector. International Journal of Managerial Studies and Research, 5(4), 119-126.

De Pinho Gomes, R. D. P., Pimentel, V. P., Landim, A. B., & Pieroni, J. P. (2012). Clinical trials in Brazil: international competitiveness and challenges. BNDES Sectorial, 36, set. 2012, 45-84.

Gofredo, T. R., & Bataglia, W. (2015). The synchronization mechanisms in strategic alliances. Administration Journal of the Federal University of Santa Maria, 8 (4), 633-649.

Hoang, H., & Rothaermel, F. T. (2016). How to manage alliances strategically. MIT Sloan Management Review, 58(1), 69-76.

Holmes Jr, R. M., Miller, T., Hitt, M. A., & Salmador, M. P. (2013). The interrelationships among informal institutions, formal institutions, and inward foreign direct investment. Journal of Management, 39(2), 531-566.

Leischnig, A., & Geigenmüller, A. (2020). Examining alliance management capabilities in university-industry collaboration. The Journal of Technology Transfer, 45(1), 9-30.

Otte-Trojel, T., Rundall, T. G., de Bont, A., & van de Klundert, J. (2017). Can relational coordination help inter-organizational networks overcome challenges to coordination in patient portals? International Journal of Healthcare Management, 10(2), 75-83.

Schilke, O., & Goerzen, A. (2010). Alliance management capability: an investigation of the construct and its measurement. Journal of management, 36(5), 1192-1219.

Shakeri, R., & Radfar, R. (2017). Antecedents of strategic alliances performance in biopharmaceutical industry: A comprehensive model Technological Forecasting and Social Change, 122, 289-302.

Williamson, O. E. (1991). Comparative economic organization: The analysis of discrete structural alternatives. Administrative Science Quarterly, 269-296.

Yoon, J., Rosales, C., & Talluri, S. (2018). Inter-firm partnerships–strategic alliances in the pharmaceutical industry. International Journal of Production Research, 56(1-2), 862-881.

Downloads

Published

2022-12-31

How to Cite

Rijhwani, N. R. (2022). A study on Institutional oversight and the effectiveness of clinical trial strategic alliances. Revista Review Index Journal of Multidisciplinary, 2(4), 15-21. https://doi.org/10.31305/rrijm2022.v02.n04.004